San
Francisco, Nov 27 The global oxygen
therapy market is expected to reach USD 18.2 billion by 2024,
according to a new study by Grand View Research, Inc. The increasing prevalence
of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease
(COPD), asthma, and obstructive sleep apnea, is a high impact rendering driver
of oxygen therapy market.
As per the estimates of
the WHO, a consequential global rise in the prevalence of asthma and other
respiratory disorders, is expected to heightened clinical urgency to treat the
aforementioned disorders and is expected to boost the demand for oxygen therapy
as the first line treatment and as a supplement in various applications.
Moreover, technological
advancements are anticipated to provide growth platforms in a wide range of new
applications such as cancer and diabetes; for instance, incorporation of flow
sensors in delivery devices to conserve and regulate the flow enabling greater
patient comfort and outcomes.
Furthermore, the
increasing focus on home healthcare solutions coupled with the development of
portable delivery devices has a major impact on the oxygen therapy market.
These aforementioned factors are expected to serve as key contributing factors
towards the growth of the oxygen therapy market over the forecast period.
Browse full research report on Oxygen
Therapy Market: www.grandviewresearch.com/industry-analysis/oxygen-therapy-market
Further key
findings from the study suggest:
- The oxygen source equipment segment
dominated the product segment in terms of revenue share in 2015owing toits
high usage rate and wide scale availability in various forms such as
liquid compressed gas, and concentrators. On the other hand, oxygen
delivery devices are expected to grow at a lucrative rate being an
indispensable part of the oxygen therapy set-ups, thereby contributing
towards the overall oxygen therapy market growth during the forecast
period.
- Oxygen concentrator spear headed
the source equipment market segment owing to rising popularity and
adoption of Portable Concentrators in emergency medicine, ambulatory, and
home settings.
- Oxygen masks dominated delivery
device market segment at over USD 800.0 million in 2015, as a consequence
of being the indispensable unit of the delivery system and greater
availability of specialty masks as per the patient’s physiological needs
- Chronic Obstructive Pulmonary
Disease (COPD) held a substantial market share of application segment and
constituted for over 37.0%of the overall revenue share, owing to presence
of unmet needs pertinent to COPD treatment, thereby propelling the demand
for oxygen therapy market
- Home Healthcare is anticipated to
grow lucratively at CAGR of 11.8% owing to associated benefits such as
long-term cost efficiency and increased mobility, propelling the demand
over the forecast period. Moreover, presence of organizations such
American Association for Homecare to promote awareness and strengthen home
healthcare are expected to provide growth platform in future to oxygen therapy
market
- The key players in this industry
include CareFusion, Corp., Tecno-Gaz Industries, GE Healthcare, Hersill,
DeVilbiss Healthcare, Philips Respironics, Inc., MAQUET Medical Systems,
Allied Healthcare Products, Smiths Medical, Fisher & Paykel Healthcare
Limited, Invacare Corporation and Teleflex Incorporated
- These industry players are adopting
strategies such as new product development, technological innovation, and
strategic collaborations, such as mergers &acquisitions, to capitalize
their industry share. For instance, in May 2015, Fisher & Paykel
Healthcare launched AIRVO nasal high-flow system to expand its product
portfolio and capture greater share of oxygen therapy market.
Browse more reports of this category by
Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the oxygen therapy
market on the basis of product, application, end-use, and region:
Global Oxygen Therapy
Product Outlook (Revenue, USD Million, 2012 - 2022)
- Oxygen Source Equipment
- Oxygen Cylinders
- Oxygen Concentrators
- Liquid Oxygen Devices
- PAP Devices
- Oxygen Delivery Device
- Oxygen Masks
- Nasal Cannula
- Venturi Masks
- Non-rebreather Masks
- Bag Valve Masks
- CPAP Masks
- Others
Global Oxygen Therapy
Application Outlook (Revenue, USD Million, 2014 - 2024)
- Chronic Obstructive Pulmonary
Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
- Others
Global Oxygen Therapy
End-Use Outlook (Revenue, USD Million, 2014 - 2024)
- Home Healthcare
- Hospital
Oxygen Therapy Regional
Outlook (Revenue, USD Million, 2014 - 2024)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
Browse press release of this report by
Grand View Research: www.grandviewresearch.com/press-release/global-oxygen-therapy-market
About Grand View Research
Grand View Research,
Inc. is a U.S. based market research and consulting company, registered in the
State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For
more information: www.grandviewresearch.com
No comments:
Post a Comment